View profile

FarmaKology Newsletter - Issue #2

Revue
 
Would you like to submit an article or some interesting news? Send whatever you have to "abdul@farmak
 

FarmaKology

March 28 · Issue #2 · View online
FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "abdul@farmakology.com".

Would you like to submit an article or some interesting news? Send whatever you have to “abdul@farmakology.com”, and happy to have it featured on our newsletter.

News
A program launched last year by the Wisconsin Alumni Research Foundation to invest in promising biotech discoveries made on the University of Wisconsin-Madison campus will also work with the La Jolla, CA-based Sanford Burnham Prebys Medical Discovery Institute, the organizations said recently.
The City of Bristol, Virginia has filed a $40 million state lawsuit accusing 19 prescription opioid manufacturers, distributors, and pharmacy benefit managers and their related companies of creating a public health emergency in the city caused by the overuse of prescription opioids.
Swiss pharma giant Novartis snagged regulatory approval  in the United States for its new multiple sclerosis treatment Mayzent (siponimod) and plans to have it available for prescribers and their patients by next week.
Doctors in Texas want the ability to sell certain drugs right from their office. Currently, Texas is one of four states where that isn’t legal.
Research
Podcasts
Integrating Care And Research With Dr Laura Esserman PharmaTalkRadio podcast
Job Opportunities
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue